Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Gefitinib can cause rare scarring hair loss.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Oral baricitinib is effective and safe for treating alopecia areata.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Clofazimine effectively treated ashy dermatosis in a patient.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Ritlecitinib can help about 14,000 people with severe hair loss.

These new skin treatments are safer and more effective with minimal side effects.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Tislelizumab can cause cutaneous lupus erythematosus.

TAK-279 effectively reduces psoriasis symptoms and is safe.

JAK inhibitors can enter the skin through hair follicles using a unique pathway.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.